查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1672731

按臨床試驗階段、方法類型、服務供應商類型和地區分類的藥物安全檢測市場

Pharmacovigilance Market, By Clinical Trial Phases, By Type of Method, By Type of Service Provider, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 175 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球藥物安全檢測市場規模估計為 80.3 億美元，預計到 2032 年將達到 140.3 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 8.3%。

報告範圍 報告詳細資訊
基準年 2024 2025 年市場規模 80.3億美元
效能資料 2020-2024 預測期 2025-2032
預測期：2025 年至 2032 年複合年成長率 8.30％ 2032 年金額預測 140.3億美元
市場佔有率。
藥物警戒市場-IMG1

近年來，全球藥物安全檢測市場經歷了顯著成長。藥物安全檢測是指與檢測、評估、理解和預防副作用及其他與藥物相關的問題的科學和活動。隨著藥物分子變得越來越複雜以及新治療方法不斷推向市場，對有效的上市後藥物安全監測的需求也日益增加。嚴格的法律規範要求對藥品進行安全監控，加上藥物副作用的增加，推動了全球對藥物安全檢測服務的需求。此外，學名藥市場的擴大和臨床試驗外包到新興地區也進一步推動了藥物安全檢測市場的發展。

市場動態

全球藥物安全檢測市場受到藥物不良反應增加、藥品核准安全法規越來越嚴格、有效治療方法需求不斷成長以及學名藥市場不斷擴大的推動。要求上市後監測的嚴格監管準則是增加藥物安全檢測服務需求的一個主要因素。此外，因安全問題而召回藥品的趨勢日益成長，迫使製藥公司將其藥物安全檢測業務委託給專業服務供應商。此外，已開發國家學名藥市場的擴張為藥物安全檢測市場參與企業提供了重大機會。然而，中小企業的預算限制以及跨地區報告藥品安全資料的複雜性對市場參與企業構成了挑戰。

研究的主要特點

  • 本報告對全球藥物安全檢測市場進行了詳細分析，並提供了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%），假設基準年為 2024 年。
  • 它還強調了各個領域的潛在商機並說明了該市場的有吸引力的投資提案矩陣。
  • 它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
  • 它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，概述了全球藥物安全檢測市場的主要企業。
  • 本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
  • 全球藥物安全檢測市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員將透過全球藥物安全檢測市場分析中使用的各種策略矩陣更輕鬆地做出決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • 一致的機會圖 (COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
  • 影響分析
  • 市場趨勢
  • 監管情景
  • 收購和合作場景
  • 資金籌措和投資
  • PEST分析
  • 波特的分析

第 4藥物安全檢測。

  • 整體影響
  • 政府舉措
  • COVID-19 市場影響

5. 2020 年至 2032 年按臨床試驗階段分類的全球藥物安全檢測市場（十億美元）

  • 介紹
  • 臨床前研究
  • 臨床試驗 I 期
  • 臨床試驗 II 期
  • 臨床試驗 III 期
  • 上市後研究或 IV 期

6. 2020 年至 2032 年按方法類型分類的全球藥物安全檢測市場（十億美元）

  • 介紹
  • 自發報道
  • 增強的 ADR 報告
  • 目標報告
  • 群組心臟事件記錄器
  • 電子病歷監控

7. 2020-2032 年全球藥物安全檢測市場（按服務供應商類型分類）（十億美元）

  • 介紹
  • 內部
  • 合約外包

8. 2020 年至 2032 年全球藥物安全檢測市場（按地區分類）（單位：十億美元）

  • 介紹
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第9章 競爭格局

  • 公司簡介
    • Accenture
    • Cognizant Technology Solutions
    • Laboratory Corporation of America Holdings（LabCorp）
    • IBM Corporation
    • QuintilesIMS（IQVIA）
    • ICON plc
    • Capgemini
    • ITClinical
    • TAKE Solutions Ltd
    • BioClinica
    • PAREXEL International Corporation
    • Wipro Ltd
    • FMD K&L
    • Linical Accelovance
    • United BioSource Corporation（UBC）
    • PRA Health Sciences
    • ArisGlobal
    • Ennov Solutions Inc

第 10 章分析師建議

  • 興衰
  • 一致的機會地圖

第 11 章 參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI1047

Global Pharmacovigilance Market is estimated to be valued at USD 8.03 Bn in 2025 and is expected to reach USD 14.03 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.3% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 8.03 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 8.30% 2032 Value Projection: USD 14.03 Bn
Figure. Pharmacovigilance Market Share (%), By Region 2025
Pharmacovigilance Market - IMG1

The global pharmacovigilance market has been witnessing significant growth in the recent years. Pharmacovigilance is defined as the science and activities relating to the detection, assessment, understanding, prevention of adverse effects or any other drug-related problems. With the growing complexity of drug molecules and the introduction of novel therapies in the market, there is an increasing need to effectively monitor the safety of drugs post marketing. Stringent regulatory framework mandating drug safety monitoring along with increasing instances of adverse drug reactions is propelling the demand for pharmacovigilance services across the globe. Furthermore, the expanding generics market and outsourcing of clinical trials to emerging regions has further boosted the pharmacovigilance market.

Market Dynamics:

The global pharmacovigilance market is driven by the rising number of adverse drug reactions, stringent safety regulations for drug approval, increasing demand for efficacious therapies, and growing generics market. Stringent regulatory guidelines mandating post marketing surveillance is a key factor augmenting the demand for pharmacovigilance services. Furthermore, rising trend of drug recalls due to safety issues has compelled pharmaceutical companies to outsource their pharmacovigilance activities to specialized service providers. Moreover, increasing generics market in developed countries offer significant opportunities for the pharmacovigilance market players. However, budget constraints of small and midsize pharmaceutical companies and complexity of reporting drug safety data across regions pose challenges to market players.

Key Features of the Study:

  • This report provides in-depth analysis of the global pharmacovigilance market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global pharmacovigilance market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Accenture, Cognizant, Laboratory Corporation of America Holdings, IBM Corporation, ArisGlobal, ICON plc., Capgemini, ITClinical, FMD K&L, and IQVIA
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global pharmacovigilance market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharmacovigilance market

Detailed Segmentation-

  • By Clinical Trial Phases
    • Total Knee Replacement
    • Partial Knee Replacement
    • Kneecap Replacement
    • Revision Knee Replacement
  • By Type of Method
    • Spontaneous Reporting
    • Intensified ADR Reporting
    • Targeted Reporting
    • Cohort Event Monitoring
    • EHR Monitoring
  • By Type of Service Provider
    • In-House
    • Contract Outsourcing
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Accenture
    • Cognizant Technology Solutions
    • Laboratory Corporation of America Holdings (LabCorp)
    • IBM Corporation
    • QuintilesIMS (IQVIA)
    • ICON plc
    • Capgemini
    • ITClinical
    • TAKE Solutions Ltd
    • BioClinica
    • PAREXEL International Corporation
    • Wipro Ltd
    • FMD K&L
    • Linical Accelovance
    • United BioSource Corporation (UBC)
    • PRA Health Sciences
    • ArisGlobal
    • Ennov Solutions Incc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Clinical Trial Phases
    • Market Snapshot, By Type of Method
    • Market Snapshot, By Type of Service Provider
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Pharmacovigilance Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Pharmacovigilance Market, By Clinical Trial Phases, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Pre-clinical Studies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Clinical Trial Phase I
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Clinical Trial Phase II
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Clinical Trial Phase III
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Post Marketing Surveillance or Phase IV
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Pharmacovigilance Market, By Type of Method, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Spontaneous Reporting
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Intensified ADR Reporting
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Targeted Reporting
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Cohort Event Monitoring
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • EHR Monitoring
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Pharmacovigilance Market, By Type of Service Provider, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • In-House
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Contract Outsourcing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Pharmacovigilance Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

  • Company Profiles
    • Accenture
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Cognizant Technology Solutions
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Laboratory Corporation of America Holdings (LabCorp)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • IBM Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • QuintilesIMS (IQVIA)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • ICON plc
    • Capgemini
    • ITClinical
    • TAKE Solutions Ltd
    • BioClinica
    • PAREXEL International Corporation
    • Wipro Ltd
    • FMD K&L
    • Linical Accelovance
    • United BioSource Corporation (UBC)
    • PRA Health Sciences
    • ArisGlobal
    • Ennov Solutions Inc

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About Us and Sales Contact